Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

1856 Ruxolitinib
929cdc33d886f2ac8bda06a5335706c0f6202fb6188273e0f04dc53e87200507

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Ruxolitinib, sold under the brand names Jakafi and Jakavi, is a medication for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea, and steroid-refractory acute graft-versus-host disease. It was developed and marketed by Incyte Corp in the US under the brand name Jakafi, and by Novartis elsewhere in the world, under the brand name Jakavi.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
1855 Next ≫
1857
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan